delta- and mu-Opioid receptor mobilization of intracellular calcium in SH-SY5Y human neuroblastoma cells

被引:61
|
作者
Connor, M
Henderson, G
机构
[1] Department of Pharmacology, University of Bristol, Bristol, BS8 1TD, University Walk
基金
英国惠康基金;
关键词
SH-SY5Y; opioids; intracellular calcium; muscarinic receptors; calcium mobilization;
D O I
10.1111/j.1476-5381.1996.tb15195.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 In this study we have investigated delta and mu opioid receptor-mediated elevation of intracellular Ca2+ concentration ([Ca2+](i)) in the human neuroblastoma cell line, SH-SY5Y. 2 The Ca2+-sensitive dye, fura-2, was used to measure [Ca2+](i) in confluent monolayers of SH-SY5Y cells. Neither the delta-opioid agonist, DPDPE ([D-Pen(2,5)]-enkephalin) nor the mu-opioid agonist, DAMGO (Tyr-D-Ala-Gly-N-Me-Phe-Gly-ol enkephalin) elevated [Ca2+](i) when applied alone. However, when either DPDPE or DAMGO was applied in the presence of the cholinoceptor agonist, carbachol (100 nM-1 mM) they evoked an elevation of [Ca2+](i) above that caused by carbachol alone. 3 In the presence of 1 mu M or 100 mu M carbachol, DPDPE elevated [Ca2+](i) with an EC(50) of 10 nM. The elevation of [Ca2+](i) was independent of the concentration of carbachol. The EC(50) for DAMGO elevating [Ca2+](i) in the presence of 1 mu M and 100 mu M carbachol was 270 nM and 145 nM respectively. 4 The delta-receptor antagonist, naltrindole (30 nM), blocked the elevations of [Ca2+](i) by DPDPE (100 nM) without affecting those caused by DAMGO while the mu-receptor antagonist, CTAP (D-Phe-Cys-Tyr-D-Trp-Arg-Pen-Thr-NH2) (100 nM-1 mu M) blocked the elevations of [Ca2+](i) caused by DAMGO (1 mu M) without affecting those caused by DPDPE. 5 Block of carbachol activation of muscarinic receptors with atropine (10 mu M) abolished the elevation of [Ca2+](i) by the opioids. The nicotinic receptor antagonist, mecamylamine (10 mu M), did not affect the elevations of [Ca2+](i) caused by opioids in the presence of carbachol. 6 Muscarinic receptor activation, not a rise in [Ca2+](i), was required to reveal the opioid response. The Ca2+ channel activator, maitotoxin (3 ng ml(-1)), also elevated [Ca2+](i) but subsequent application of opioid in the presence of maitotoxin caused no further changes in [Ca2+](i). 7 The elevations of [Ca2+](i) by DPDPE and DAMGO were abolished by pretreatment of the cells with pertussis toxin (200 ng ml(-1), 16 h). This treatment did not significantly affect the response of the cells to carbachol. 8 The opioids appeared to elevate [Ca2+](i) by mobilizing Ca2+ from intracellular stores. Both DPDPE and DAMGO continued to elevate [Ca2+](i) when applied in nominally Ca2+-free external buffer or when applied in a buffer containing a cocktail of Ca2+ entry inhibitors. Thapsigargin (100 nM), an agent which discharges intracellular Ca2+ stores, also blocked the opioid elevations of [Ca2+](i). 9 delta and mu opioids did not appear to mobilize intracellular Ca2+ by modulating the activity of protein kinases. The application of H-89 (10 mu M), an inhibitor of protein kinase A, H-7 (100 mu M), an inhibitor of protein kinase C, protein kinase A and cyclic GMP-dependent protein kinase, or Bis I, an inhibitor of protein kinase C, did not alter the opioid mobilization of [Ca2+](i). 10 Thus, in SH-SY5Y cells, opioids can mobilize Ca2+ from intracellular stores but they require ongoing muscarinic receptor activation. Opioids do not elevate [Ca2+](i) when applied alone.
引用
收藏
页码:333 / 340
页数:8
相关论文
共 50 条
  • [21] Propofol increases μ-opioid receptor expression in SH-SY5Y human neuroblastoma cells
    Li, Zuojun
    Pei, Qi
    Cao, Lijun
    Xu, Linyong
    Zhang, Bikui
    Liu, Shikun
    MOLECULAR MEDICINE REPORTS, 2012, 6 (06) : 1333 - 1336
  • [22] INTERACTION AMONG MU-OPIOID RECEPTORS AND ALPHA-2-ADRENOCEPTORS ON SH-SY5Y HUMAN NEUROBLASTOMA-CELLS
    LAMEH, J
    EIGER, S
    SADEE, W
    EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1992, 227 (01): : 19 - 24
  • [23] Activation of the G Protein-Coupled Estrogen Receptor Elicits Store Calcium Release and Phosphorylation of the Mu-Opioid Receptors in the Human Neuroblastoma SH-SY5Y Cells
    Ding, Xiaowei
    Gao, Ting
    Gao, Po
    Meng, Youqiang
    Zheng, Yi
    Dong, Li
    Luo, Ping
    Zhang, Guohua
    Shi, Xueyin
    Rong, Weifang
    FRONTIERS IN NEUROSCIENCE, 2019, 13
  • [24] INHIBITION OF AN N-LIKE CALCIUM-CHANNEL CURRENT BY MU-OPIOID RECEPTOR ACTIVATION IN THE HUMAN NEUROBLASTOMA CELL-LINE SH-SY5Y
    HENDERSON, G
    SEWARD, EP
    JOURNAL OF PHYSIOLOGY-LONDON, 1990, 422 : P19 - P19
  • [25] Delta opioid receptor antagonism/inverse agonism and its effect on mu opioid receptor signaling in SH-SY5Y cells
    Griggs, Nicholas
    Mosberg, Henry
    Traynor, John
    FASEB JOURNAL, 2017, 31
  • [26] Regulation of Mu opioid receptor mRNA levels by activation of protein kinase C in human SH-SY5Y neuroblastoma cells
    Gies, EK
    Peters, DM
    Gelb, CR
    Knag, KM
    Peterfreund, RA
    ANESTHESIOLOGY, 1997, 87 (05) : 1127 - 1138
  • [27] Butyrylcholinesterase in SH-SY5Y human neuroblastoma cells
    Onder, Seda
    Schopfer, Lawrence M.
    Jiang, Wei
    Tacal, Ozden
    Lockridge, Oksana
    NEUROTOXICOLOGY, 2022, 90 : 1 - 9
  • [28] MU AND DELTA OPIOID RECEPTORS DIFFERENTIALLY COUPLE TO G-PROTEIN SUBTYPES IN MEMBRANES OF HUMAN NEUROBLASTOMA SH-SY5Y CELLS
    LAUGWITZ, KL
    OFFERMANNS, S
    SPICHER, K
    SCHULTZ, G
    NEURON, 1993, 10 (02) : 233 - 242
  • [29] TPA regulates mu opiate receptor mRNA levels in human SH-SY5Y neuroblastoma cells
    Peterfreund, RA
    Gies, EK
    ANESTHESIOLOGY, 1996, 85 (3A) : A655 - A655
  • [30] Opioid Receptor Gene Expression in Human Neuroblastoma SH-SY5Y Cells Following Tapentadol Exposure
    Caputi, Francesca Felicia
    Carretta, Donatella
    Tzschentke, Thomas M.
    Candeletti, Sanzio
    Romualdi, Patrizia
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2014, 53 (04) : 669 - 676